A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes

Updated 06/14/2024

Status Completed

Clinical Trial Summary

A study of ASP2151 in subjects with recurrent outbreaks of genital herpes.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Herpes Genitalis

Clinical Trial Details

NCT number	NCT00486200
Study type	Interventional
Source	Astellas Pharma Inc
Contact
Status	Completed
Phase	Phase 2
Start date	June 21, 2007
Completion date	August 12, 2008

See also
	Status	Clinical Trial	Phase
	Completed	`NCT02837575` - Safety and Efficacy Study of Herpes Simplex Virus Type 2 (HSV-2) Therapeutic DNA Vaccine	Phase 2
	Completed	`NCT02852876` - Study to Evaluate the Safety and Pharmacokinetics of Single Doses of ASP2151 in Healthy Male Subjects and the Effects of Food	Phase 1
	Completed	`NCT04664127` - Study of the Efficacy and Safety of Combined Treatment of Patients With Severe Herpes Simplex (HSV) Infection by Valacyclovir and Interferon Inducer Kagocel
	Completed	`NCT00405821` - Acyclovir to Treat Patients Co-infected With HIV and Herpes Viruses in Uganda	Phase 2
	Completed	`NCT04165122` - Monoclonal Antibody Therapy Against Chronic Herpes Simplex Virus 2 Infection	Phase 2
	Completed	`NCT00158483` - Anti-Herpetic Treatment of Genital Ulcer : Effect on HIV & Herpes Shedding (ANRS 1212)	Phase 2
	Terminated	`NCT00079911` - A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection In HIV-Infected Persons	Phase 4
	Active, not recruiting	`NCT04950712` - An Epidemiological Study to Assess Performance of Using Healthcare Tools to Understand Genital Herpes Simplex Virus-2 (HSV-2) in Patients ≥ 18 Years of Age in the United States and Europe.
	Completed	`NCT00158860` - A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of Herpes Simplex Virus HSV-2 Genital Herpes In Newly Diagnosed Patients. VALTREX® Tablet is a Trademark of the GlaxoSmithKline Group of Companies.	Phase 4
	Active, not recruiting	`NCT00005663` - A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected Patients	Phase 3
	Active, not recruiting	`NCT04073082` - Safety and Efficacy of Laser Therapy in Gynaecology
	Terminated	`NCT00122525` - Effect of Male Circumcision on HIV Incidence (ANRS 1265)	Phase 3
	Completed	`NCT00158509` - Randomised Controlled Trial Assessing the Impact of Genital Herpes Suppressive Therapy on HIV Shedding	Phase 2
	Completed	`NCT00076232` - A Study of Acyclovir to Help Prevent HIV Infection in People With Genital Herpes	Phase 3
	Completed	`NCT00023582` - HIV and Genital Herpes Among High-Risk Men Who Have Sex With Men (MSM) in Lima, Peru	N/A